In line with these findings, our results demonstrate that WTIP expression is significantly reduced both in AML cell lines and clinical specimens compared with normal controls, and low levels of WTIP are associated with decreased overall survival in AML patients. The gene discussed is WTIP; the disease is acute myeloid leukemia.